Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript March 24, 2026 Fennec Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $0.

Welcome to Fennec Pharmaceuticals' Fourth Quarter and Full Year 2025 Earnings and Corporate Update Conference Call. [Operator Instructions]. As a reminder, today's conference call is being recorded.

Q3 2026 Earnings Call March 25, 2026 10:00 AM EDTCompany ParticipantsJared Mattingley - VP, Treasurer, Investor Relations ...

Payroll software offers thorough automation, error-checking, and setup tools, but that doesn't mean you aren't responsible ...

When most people hear the term NGO (Non-Governmental Organisation), they tend to think of impact--community projects, humanitarian efforts, and driving social change.Taxes, however, are rarely part of ...

Human Interest has experienced rapid adoption among financial advisors nationwide, with over 650 leading advisory firms now using Human Interest technology, which automates the setup, administration, ...

New ebankIT report reveals the five strategic shifts redefining digital transformation for retail banks and credit ...

Both employees and employers pay FICA taxes at the same rate. FICA taxes are divided into two parts: Social Security tax and ...